MCRB · Seres Therapeutics, Inc. · Proposed Sales
$3.35
-0.13 (-3.74%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 5, 2026
Market Cap
$34.99M
Shares
9.94M
Volume · Sep 30
54.61K
Avg daily vol (3M)
73.92K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.